Background: Several recent guidelines recommend assessment of patients with TIA within 24
The risk of recurrent stroke in the week after a TIA or minor stroke is up to 10%. [1] [2] [3] [4] About 150,000 suspected TIAs and minor strokes are referred to secondary care for assessment and investigation in England alone each year, 5 and rates are similar in the United States. 6 These "warning" events provide a short window of opportunity for prevention, 7 and in recognition of this, the most recent clinical guidelines all now recommend that high-risk patients with TIA should be assessed within 24 hours of the event. [8] [9] [10] [11] [12] However, the appropriateness of the new 24-hour recommendation depends on three key issues. First, what is the risk of recurrent stroke within the first few hours, which might be prevented by even more urgent assessment? Second, what proportion of patients who have a stroke during the first 24 hours after a TIA seek medical attention prior to the recurrent stroke? Third, do existing risk scores reliably predict the risk of recurrent stroke in the hyperacute phase after TIA such that very high risk individuals might be triaged for emergency care? The ABCD system, which the guidelines recommend be used to identify high-risk cases, 3, 13 was derived for prediction of the risk of recurrent stroke at 7 days, and there are no published data on its ability to predict recurrence within the first few hours.
In a previous study of the timing of TIAs in patients presenting with stroke, we found that 44% of TIAs during the previous 14 days occurred on same day as the stroke or on the previous day. 7 However, this study was retrospective, with many patients assessed several weeks after the stroke, and was therefore potentially prone to recall bias, no data were available on whether patients had sought medical attention prior to the stroke, and the clinical characteristics necessary to calculate the ABCD 2 score were not collected. In the absence of reliable prospectively collected data, we performed the first population-based study of risk of stroke during the 24 hours after TIA, with stratification by the ABCD 2 score and by whether patients sought medical attention prior to the stroke.
METHODS
The Oxford Vascular Study (OXVASC) is a population-based study of all stroke and all TIA in 91,105 individuals of all ages registered with 63 general practitioners in Oxfordshire, UK. OXVASC is approved by our local ethics review committee. The study methods have been described elsewhere. 14, 15 Briefly, multiple overlapping methods of "hot pursuit" were used to achieve near complete ascertainment of all individuals presenting to medical attention with TIA or stroke, [14] [15] [16] including the following:
1. A daily (weekdays only), urgent open-access TIA clinic to which participating general practitioners and the local accident and emergency department (A&E) send all individuals with suspected TIA or stroke who they would not normally admit to hospital 2. Daily assessment of admissions to medical, stroke, neurology, and other relevant wards 3. Daily searches of the local A&E attendance register In order to identify any patients missed by hot pursuit, such as patients who presented late, patients who were referred to other services, or patients who were not referred to secondary care, we also performed several types of "cold pursuit": monthly computerized searches of family doctor diagnostic coding, hospital discharge codes, and all cranial and carotid imaging studies performed in local hospitals, and all death certifications in our study population.
All patients were consented and seen by study physicians as soon as possible after their initial presentation. All patients presenting with stroke were asked about symptoms of TIA during the previous 24 hours. Event characteristics and risk factors were recorded and all patients underwent brain imaging, with CT or MRI as appropriate. All cases were subsequently reviewed by the study senior neurologist (P.M.R.) and classified as probable or definite TIA or stroke or other condition using standard definitions. 14, 15 We excluded patients in whom it was impossible to obtain a definite history of TIAs because they were aphasic, confused, or unconscious. This article includes all cases with events from April 2002 to March 2007.
All patients were followed up at 30 days by a study nurse or physician. Recurrent symptoms, medications, and disability scores were recorded. All recurrent strokes that presented to medical attention would also be identified acutely by ongoing daily case ascertainment within OXVASC. All patients with recurrent events were reassessed by a study physician and reviewed by PMR. Etiologic classification of the early recurrent strokes was performed according to the TOAST classification.
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Analysis. We restricted analysis to the risk of stroke after the first probable or definite TIA in the study period. We analyzed the risk of stroke in the first 24 hours after TIA both including and excluding patients who did not seek medical attention for their initial symptoms and only presented after the recurrent stroke. A recurrent stroke was defined as a new or persistent neurologic symptom in a patient in whom the initial symptoms had already substantially or fully recovered. In patients who had recurrent stroke within 24 hours of an initial event, the following two types of preceding TIA were defined:
1. Cases in whom the initial symptoms had definitely fully resolved prior to the stroke (definite TIA) 2. Cases in whom the initial symptoms were rapidly resolving and had almost completely recovered prior to the stroke, such that complete resolution within 24 hours would have been highly likely (probable TIA)
In cases where there was no, or only partial, resolution of symptoms prior to recurrent stroke, the initial event was classified as a minor stroke.
Analyses of time to event were performed from two separate time points:
1. Time of onset of the TIA 2. Time that the patient first called for medical attention (i.e., time that he or she called the family doctor, or presented to the emergency department, or called for an ambulance)
The risks of stroke during the 6, 12, and 24 hours after TIA were determined in relation to the ABCD 2 score, a seven-point validated clinical risk prediction tool for triage assessment of TIA.
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RESULTS
Complete baseline data and complete follow-up to 30 days were available on all 1,247 first TIA or strokes. Table 1 shows the clinical characteristics of all 488 first TIAs.
Of the 488 first TIAs, 463 had no stroke within 24 hours. In the remaining 25 cases, 23 of whom had incident TIAs, a recurrent stroke occurred within 24 hours of onset of the TIA. The symptoms of the TIA had completely resolved prior to the recurrence in 22 cases (definite TIA), lasting less than 60 minutes in 9 cases. In three cases (probable TIA), the symptoms had almost completely recovered at the time of onset of the stroke, which occurred at 4, 12, and 13 hours after onset of the TIA. A further 10 patients with a recurrent stroke within 24 hours were excluded because the symptoms of the initial event had no more than partially resolved prior to the recurrent event.
Of the 488 first TIAs, 17 had a recurrent stroke within 24 hours of first calling for medical attention. The symptoms of the TIA had completely resolved prior to the recurrence in 14 cases (definite TIA) and had almost completely recovered in three cases (probable TIA; same three cases as above). Figure 1 shows the 24-hour risk of stroke after TIA. The risks of stroke within 6, 12, and 24 hours of a TIA were 1.2% (95% confidence interval [CI] 0.2-2.2, 6 cases), 2.0% (95% CI 0.8 -3.2, 10 cases), and 5.1% (95% CI 3.1-7.1, 25 cases). The equivalent risks measured from the time of first calling for medical attention after the TIA were 1.2% (95% CI 0.2-2.2, 6 cases), 2.0% (95% CI 0.8 -3.2, 10 cases), and 3.5% (95% CI 1.9 -5.1, 17 cases) (figure 1). Of the 25 cases with recurrent stroke within 24 hours, 14 (56%) patients were already on aspirin at the time of the initial TIA, 5 (20%) were on a statin, and 12 (48%) were on one or more antihypertensive drugs. Figure 2 shows the distribution of time from first TIA to stroke. The 25 cases with recurrence within 24 hours accounted for 52% of the 48 strokes during the 7 days and 42% of the 59 strokes during the 30 days after first TIA. Of the recurrences within 24 hours, 14 (56%) had an NIHSS Ն3 at initial assessment after the recurrent stroke, 12 (48%) were associated with a Rankin score Ն3 at 1 month follow-up, and 3 were fatal.
Sixteen (64%) of the 25 patients with TIA with recurrent stroke within 24 hours of onset of the TIA sought medical attention prior to the stroke, of whom 7 (44%) did not know the cause of their symptoms, 7 (44%) thought it was a stroke or ministroke, and 2 were uncertain. Seven (44%) contacted their family practitioner, five called for an emergency ambulance (one was seen by the paramedics and left at home and four were taken to hospital, one of whom had a stroke on arrival at the emergency department), two attended the emergency room directly, and two were inpatients at the time of their event and notified medical staff. At the time of the initial TIA, 10 (56%) of these 16 patients were already on aspirin, 4 (25%) were on a statin, and 8 (50%) were on one or more antihypertensive drugs. None received additional antiplatelet treatment prior to the recurrence. However, the median (interquartile range) time from seeking medical attention to Table 1 Baseline characteristics of patients with TIA included in the study Diabetes, n (%) 65 (13) 4 (16) 61 (13) Angina or myocardial infarction, n (%) 100 (20) 8 (32) 92 (20) Peripheral vascular disease, n (%) 29 (6) 2 (8) 27 (6) Previously diagnosed atrial fibrillation, n (%) 78 (16) 6 (24) 72 (16) Current smoker, n (%) 66 (14) 3 (12) 63 (14) Figure 1 Risk of recurrent stroke within 24 hours of onset of a probable or definite TIA and within 24 hours of first calling for medical attention after a probable or definite TIA recurrence in these 16 patients was only 6.9 (2.0 -18.0) hours. Patients recruited to the EXPRESS study 18 were nested within this cohort and of the 337 patients with TIA who were referred to the EXPRESS Study clinic, five cases had a recurrent stroke within 24 hours and sought medical attention for their initial TIA. All five had their recurrence before being seen in the clinic (three in phase 1 of the study and two in phase 2). Table 2 shows the 6-, 12-, and 24-hour risks of stroke following TIA stratified by the ABCD 2 score, along with the parallel analysis based on time from first calling for medical attention after the TIA. The score was highly predictive (p ϭ 0.00025) of recurrent stroke within 24 hours. Risk of stroke was 2.0% at a score Յ4, 6.5% at 5 (6/92), 11.8% at 6 (11/93), and 33% at 7 (2/6). Nineteen of 25 recurrences had an ABCD 2 score of five or more. A similar pattern was seen at 6 and 12 hours, with patients with scores Ն5 having greater risks of stroke than those with lower scores: 6-hour risk, 5/191 (2.6%) vs 1/297 (0.3%); 12-hour risk, 9/191 (4.7%) vs 1/297 (0.3%). An ABCD 2 score of five or more also identified the majority of patients who had a stroke within 24 hours of seeking medical attention (14/17, 82%): 6-hour risk, 5/191 (2.6%) vs 1/297 (0.3%); 12-hour risk, 9/191 (4.7%) vs 1/297 (0.3%); 24-hour risk, 14/191 (7.3%) vs 3/297 (1%).
No particular etiologic subtype (TOAST classification) was predominant among the 25 TIAs with recurrent stroke within 24 hours of onset: large artery atherosclerosis in 3, cardioembolic in 4, small vessel disease in 9, mixed large artery and cardioembolic in 1, mixed large artery and small vessel disease in 1, undetermined in 5, unknown in 1, and other cause in 1.
To understand the health economic burden represented by seeing as an emergency those patients with an ABCD 2 above a particular cutpoint, we determined the number of cases that would need to be seen per year in a population of 500,000 and the expected number of strokes within the first 24 hours (table 3) . For example, based on the rates observed in OXVASC, the expected number of cases with an ABCD 2 score Ն6 seeking medical attention prior to a recurrent stroke would be 109/500,000/year, 10 of whom would be expected to have a stroke within the first 24 hours without emergency assessment and treatment.
DISCUSSION Determining the risk of stroke within 24 after a TIA is methodologically difficult as differentiating between a stroke in evolution and a very early recurrence can be problematic, particularly if only routinely collected data are available. By ascertaining patients as soon as possible after the event and by assessing them ourselves in the acute phase, including detailed recording of the exact timing and evolution of the clinical syndrome, we have been able to gather as accurate an estimate as possible of the risk of early recurrent stroke. In this first rigorous prospective population-based study of the risk of stroke within 24 hours of a TIA, we found a stroke rate of about 5%, with half of all recurrent strokes within 7 days occurring in the first 24 hours, and half of these very early recurrent strokes being disabling or fatal. Analyses of risk of stroke from time of first Time from onset of TIA to onset of stroke in all patients who had a stroke within 1 month of a TIA seeking medical attention, which is perhaps more clinically relevant, were similar. Previous studies looking at risk of stroke following TIA have used various methods to estimate risk. 19 In a recent systematic review including 18 independent cohorts, which reported stroke risk in 10,126 patients with TIA, the pooled stroke risk was 5.2% (95% CI 3.9 -6.5) at 7 days, but ranged from 0% to 12.8%. 4 Most of the variation in reported risk between studies could be accounted for by differences in methods, with population-based studies that had face-to-face follow-up reporting the highest risks of stroke. 2 Previous standard definitions of recurrent stroke have tended to exclude all new symptoms or deteriorations within 24 hours of the initial event, 19 and it has often been unclear whether such early recurrences were included in previous studies of the early risk of stroke after TIA. [20] [21] [22] [23] [24] [25] [26] [27] Our data show that exclusion of such cases would significantly underestimate the true early risk of stroke. Table 2 The 6-, 12-, and 24-hour risk of stroke after TIA stratified according to the ABCD 2 score in patients with probable or definite TIA CI ϭ confidence interval. OXVASC ϭ Oxford Vascular Study; CI ϭ confidence interval.
In our previous retrospective study of the timing of TIAs in patients presenting with stroke, we found that 44% of TIAs during the previous 14 days occurred on the same day as the stroke or on the previous day, 7 but many patients were assessed several weeks after the stroke and might therefore have either forgotten about any preceding TIA or have been prone to recall bias. It was also unknown whether patients had sought medical attention for these preceding TIAs. The current prospective study has, however, confirmed the very high rate of TIA shortly before stroke.
The ABCD 2 score was highly predictive of early recurrent stroke. The score also performed well in the analysis based on risk from time of first calling for medical attention and is therefore likely to be clinically useful for triage of patients with TIA in the hyperacute phase, as well as in public education.
Our study had some potential limitations. First, we cannot be completely precise about the risk of stroke within 24 hours of a TIA because not all patients with TIA seek medical attention. However, our analysis of risk from the time of first seeking medical attention revealed very similar risks. Secondly, we might have underestimated the early risk of stroke slightly because some patients with major stroke with a preceding TIA may not have been identified because we excluded those in whom it was impossible to obtain a definite history of TIAs because they were aphasic, confused, or unconscious. Third, our validation of the ABCD 2 score for recurrences in the first few hours after TIA was based on relatively small numbers of outcomes and so further studies would help to confirm or refute our findings. Fourth, our study included patients recruited into the EXPRESS study, 18 phase 2 of which involved more urgent investigation and treatment. However, the two patients who sought medical attention and were referred to the phase 2 EXPRESS clinic prior to their recurrent stroke had the recurrence before being seen in the clinic.
The EXPRESS study showed that urgent intervention after TIA was highly effective in preventing recurrent stroke after patients sought medical attention, 18 and this observation is supported by other studies in which patients have been treated urgently and intensively. 24, 28 However, relatively few patients in EXPRESS were treated within a few hours of onset of their TIA. Our current study has shown that the majority of patients who had a recurrent stroke within 24 hours of a TIA did seek medical attention, usually from their family doctor, prior to their recurrence but they were not treated or sent to the EXPRESS clinic as an emergency. However, the fact that the majority of patients sought medical attention prior to their recurrence indicates that emergency triage and treatment are feasible, if front-line services recognize the need.
Our results also have implications for trials of treatment in the acute phase after TIA, such as trials of combination antiplatelet treatment. Although the MATCH trial of aspirin plus clopidogrel vs clopidogrel alone showed no benefit of longer-term combination treatment, there was a beneficial trend in patients randomized within 7 days of a TIA or stroke, 29 which was supported by the findings of the CARESS trial, 30, 31 and more recently by the results of the Fast Assessment of Stroke and Transient Ischemic Attack to prevent Early Recurrence (FASTER) Trial, in which aspirin plus clopidogrel vs aspirin alone tended to reduce the risk of recurrent stroke in patients who had had a TIA or minor ischemic stroke within the previous 24 hours. 32 However, there was a clinically significant risk of major bleeding in FASTER, as in similar trials of longer-term treatment with aspirin plus clopidogrel. 30, 33, 34 Further larger trials of aspirin plus clopidogrel are planned in the hyperacute phase after TIA (Ͻ12 hours after onset), including FASTER 2 and POINT. Our results suggest that large phase 3 trials in the hyperacute phase are feasible. Based on the planned inclusion and exclusion criteria for these two trials (unpublished protocols), the proportion of potentially eligible patients calculated from our population-based cohort would be 39% (189/488) for FASTER and 40% (196/488) for POINT. The expected 24-hour risk of stroke after seeking medical attention using these criteria would be 4.8% (95% CI 1.9 -7.7) and 3.6% (95% CI 1.1-6.1).
